View Daily Data Tracking History
View Bill Text
View Statement of Purpose / Fiscal Impact
H0704.................................................by HEALTH AND WELFARE
CONTROLLED SUBSTANCES - Amends existing law to include gamma
hydroxybutyrate (GHB) as a controlled substance.
02/13 House intro - 1st rdg - to printing
02/16 Rpt prt - to Health/Wel
02/27 Rpt out - rec d/p - to 2nd rdg
03/02 2nd rdg - to 3rd rdg
03/03 3rd rdg - PASSED - 67-0-3
AYES -- Alltus, Barraclough, Barrett, Bell, Bieter, Bivens,
Black(15), Black(23), Boe, Bruneel, Callister, Campbell, Chase,
Clark, Crane, Crow, Cuddy, Deal, Denney, Ellsworth, Field(13),
Field(20), Gagner, Geddes, Gould, Hadley, Hansen, Henbest, Hornbeck,
Jaquet, Jones(9), Jones(22), Jones(20), Judd, Kellogg, Kempton,
Kendell, Kjellander, Kunz, Lake, Linford, Loertscher, Mader, Marley,
McKague, Meyer, Miller, Mortensen, Newcomb, Pischner, Pomeroy,
Reynolds, Richman, Ridinger, Sali, Schaefer, Stevenson, Stoicheff,
Stone, Stubbs, Tilman, Tippets, Trail, Watson, Wheeler, Wood,
Zimmermann
NAYS -- None
Absent and excused -- Robison, Taylor, Mr Speaker
Floor Sponsors - Gould, Black(23)
Title apvd - to Senate
03/04 Senate intro - 1st rdg - to Health/Wel
03/13 Rpt out - rec d/p - to 2nd rdg
03/16 2nd rdg - to 3rd rdg
03/18 3rd rdg - PASSED - 34-0-1
AYES--Andreason, Boatright, Branch, Bunderson, Burtenshaw, Cameron,
Crow, Danielson, Darrington, Deide, Dunklin, Frasure, Geddes,
Hawkins, Ingram, Ipsen, Keough, King, Lee, McLaughlin, Noh, Parry,
Richardson, Riggs, Risch, Sandy, Schroeder, Sorensen, Stennett,
Sweeney, Thorne, Twiggs, Wheeler, Whitworth
NAYS--None
Absent and excused--Hansen
Floor Sponsor - King
Title apvd - to House
03/19 To enrol - rpt enrol - Sp signed
Pres signed - to Governor
03/20 Governor signed
Session Law Chapter 160
Effective: 07/01/98
H0704|||| LEGISLATURE OF THE STATE OF IDAHO |||| Fifty-fourth Legislature Second Regular Session - 1998IN THE HOUSE OF REPRESENTATIVES HOUSE BILL NO. 704 BY HEALTH AND WELFARE COMMITTEE 1 AN ACT 2 RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT; AMENDING SECTION 37-2705, 3 IDAHO CODE, TO INCLUDE GAMMA HYDROXYBUTYRATE (GHB) AS A CONTROLLED SUB- 4 STANCE UNDER SCHEDULE I. 5 Be It Enacted by the Legislature of the State of Idaho: 6 SECTION 1. That Section 37-2705, Idaho Code, be, and the same is hereby 7 amended to read as follows: 8 37-2705. SCHEDULE I. (a) The controlled substances listed in this section 9 are included in schedule I. 10 (b) Any of the following opiates, including their isomers, esters, 11 ethers, salts, and salts of isomers, esters, and ethers, unless specifically 12 excepted, whenever the existence of these isomers, esters, ethers and salts is 13 possible within the specific chemical designation: 14 (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)- 15 4-piperidinyl]-N-phenylacetamide); 16 (2) Acetylmethadol; 17 (3) Allylprodine; 18 (4) Alphacetylmethadol (except levo-alphacetylmethadol also known as 19 levo-alpha-acetylmethadol, levomethadyl acetate or LAAM); 20 (5) Alphameprodine; 21 (6) Alphamethadol; 22 (7) Alpha-methylfentanyl; 23 (8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4- 24 piperidinyl]-N-phenylpropanamide); 25 (9) Benzethidine; 26 (10) Betacetylmethadol; 27 (11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N- 28 phenylpropanamide); 29 (12) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl) 30 -3-methyl-4-piperidinyl]-N-phenylpropanamide); 31 (13) Betameprodine; 32 (14) Betamethadol; 33 (15) Betaprodine; 34 (16) Clonitazene; 35 (17) Dextromoramide; 36 (18) Diampromide; 37 (19) Diethylthiambutene; 38 (20) Difenoxin; 39 (21) Dimenoxadol; 40 (22) Dimepheptanol; 41 (23) Dimethylthiambutene; 42 (24) Dioxaphetyl butyrate; 43 (25) Dipipanone; 2 1 (26) Ethylmethylthiambutene; 2 (27) Etonitazene; 3 (28) Etoxeridine; 4 (29) Furethidine; 5 (30) Hydroxypethidine; 6 (31) Ketobemidone; 7 (32) Levomoramide; 8 (33) Levophenacylmorphan; 9 (34) 3-Methylfentanyl; 10 (35) 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4- 11 piperidinyl]-N-phenylpropanamide); 12 (36) Morpheridine; 13 (37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); 14 (38) Noracymethadol; 15 (39) Norlevorphanol; 16 (40) Normethadone; 17 (41) Norpipanone; 18 (42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- 19 piperidinyl] propanamide); 20 (43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine); 21 (44) Phenadoxone; 22 (45) Phenampromide; 23 (46) Phenomorphan; 24 (47) Phenoperidine; 25 (48) Piritramide; 26 (49) Proheptazine; 27 (50) Properidine; 28 (51) Propiram; 29 (52) Racemoramide; 30 (53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- 31 propanamide); 32 (54) Tilidine; 33 (55) Trimeperidine. 34 (c) Any of the following opium derivatives, their salts, isomers and 35 salts of isomers, unless specifically excepted, whenever the existence of 36 these salts, isomers and salts of isomers is possible within the specific 37 chemical designation: 38 (1) Acetorphine; 39 (2) Acetyldihydrocodeine; 40 (3) Benzylmorphine; 41 (4) Codeine methylbromide; 42 (5) Codeine-N-Oxide; 43 (6) Cyprenorphine; 44 (7) Desomorphine; 45 (8) Dihydromorphine; 46 (9) Drotebanol; 47 (10) Etorphine (except hydrochloride salt); 48 (11) Heroin; 49 (12) Hydromorphinol; 50 (13) Methyldesorphine; 51 (14) Methyldihydromorphine; 52 (15) Morphine methylbromide; 53 (16) Morphine methylsulfonate; 54 (17) Morphine-N-Oxide; 55 (18) Myrophine; 3 1 (19) Nicocodeine; 2 (20) Nicomorphine; 3 (21) Normorphine; 4 (22) Pholcodine; 5 (23) Thebacon. 6 (d) Hallucinogenic substances. Any material, compound, mixture or prepa- 7 ration which contains any quantity of the following hallucinogenic substances, 8 their salts, isomers and salts of isomers, unless specifically excepted, when- 9 ever the existence of these salts, isomers, and salts of isomers is possible 10 within the specific chemical designation (for purposes of this paragraph only, 11 the term "isomer" includes the optical, position and geometric isomers): 12 (1) 4-bromo-2,5-dimethoxy amphetamine; 13 (2) 2,5-dimethoxyamphetamine; 14 (3) 4-bromo-2,5-dimethoxyphenethylamine (some other names: alpha- 15 desmethyl DOB, 2C-B); 16 (4) 2,5-dimethoxy-4-ethylamphetamine (another name: DOET); 17 (5) 4-methoxyamphetamine (PMA); 18 (6) 5-methoxy-3,4-methylenedioxy-amphetamine; 19 (7) 4-methyl-2,5-dimethoxy-amphetamine (DOM, STP); 20 (8) 3,4-methylenedioxy amphetamine; 21 (9) 3,4-methylenedioxymethamphetamine (MDMA); 22 (10) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha- 23 methyl-3,4 (methylenedioxy) phenethylamine, and N-ethyl MDA, MDE, MDEA); 24 (11) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy- 25 alpha-methyl-3,4(methylenedioxy) phenethylamine, and N-hydroxy MDA); 26 (12) 3,4,5-trimethoxy amphetamine; 27 (13) Alpha-ethyltryptamine (some other names: etryptamine, 28 3-(2-aminobutyl) indole); 29 (14) Bufotenine; 30 (15) Diethyltryptamine (DET); 31 (16) Dimethyltryptamine (DMT); 32 (17) Ibogaine; 33 (18) Lysergic acid diethylamide; 34 (19) Marihuana; 35 (20) Mescaline; 36 (21) Parahexyl; 37 (22) Peyote; 38 (23) N-ethyl-3-piperidyl benzilate; 39 (24) N-methyl -3- piperidyl benzilate; 40 (25) Psilocybin; 41 (26) Psilocyn; 42 (27) Tetrahydrocannabinols. Synthetic equivalents of the substances con- 43 tained in the plant, or in the resinous extractives of Cannabis, sp. 44 and/or synthetic substances, derivatives, and their isomers with similar 45 chemical structure and pharmacological activity such as the following: 46 cis or trans tetrahydrocannabinol, and their optical isomers, exclud- 47 ing dronabinol in sesame oil and encapsulated in a soft gelatin capsule in 48 a drug product approved by the U.S. Food and Drug Administration. 49 cis or trans tetrahydrocannabinol, and their optical isomers. 50 cis or trans tetrahydrocannabinol, and its optical isomers. (Since 51 nomenclature of these substances is not internationally standardized, com- 52 pounds of these structures, regardless of numerical designation of atomic 53 positions are covered.) 54 (28) Ethylamine analog of phencyclidine (N-ethyl -1- phenylcyclohexylamine 55 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl) ethylamine, 4 1 cyclohexamine, PCE; 2 (29) Pyrrolidine analog of phencyclidine: 1-(phenylcyclohexy1) 3 -pyrrolidine, PCPy, PHP; 4 (30) Thiophene analog of phencyclidine 5 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, 6 TPCP, TCP; 7 (31) 1-[1-(2-thienyl) cyclohexyl] pyrrolidine another name: TCPy. 8 (e) Any material, compound, mixture or preparation which contains any 9 quantity of the following substances having a depressant effect on the central 10 nervous system, including its salts, isomers, and salts of isomers wherever 11 the existence of such salts, isomers, and salts of isomers is possible within 12 the specific chemical designation: 13 (1) Gamma hydroxybutyrate (GHB); 14 (2) Flunitrazepam (also known as "R2", "Rohypnol"); 15 (23 ) Mecloqualone; 16 (34 ) Methaqualone. 17 (f) Stimulants. Unless specifically excepted or unless listed in another 18 schedule, any material, compound, mixture, or preparation which contains any 19 quantity of the following substances having a stimulant effect on the central 20 nervous system, including its salts, isomers, and salts of isomers: 21 (1) Aminorex (some other names: aminoxaphen, 22 2-amino-5-phenyl-2-oxazoline, or 4,5-dihydro-5-phenyl-2-oxazolamine); 23 (2) Cathinone (some other names: alpha-aminopropiophenone, 24 2-aminopropiophenone and norephedrone); 25 (3) Fenethylline; 26 (4) Methcathinone (some other names: 2-(methyl-amino)-propiophenone, 27 alpha-(methylamino)-propiophenone, N-methylcathinone, AL-464, AL-422, 28 AL-463 and UR1423); 29 (5) (t)cis-4-methylaminorex 30 [(+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine]; 31 (6) N-ethylamphetamine; 32 (7) N,N-dimethylamphetamine (also known as: N,N-alpha-trimethyl- 33 benzeneethanamine). 34 (g) Temporary listing of substances subject to emergency scheduling. Any 35 material, compound, mixture or preparation which contains any quantity of the 36 following substances: 37 (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its 38 optical isomers, salts and salts of isomers. 39 (2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide 40 (thenylfentanyl), its optical isomers, salts and salts of isomers. 41 (3) 4-methylaminorex (also known as 2-amino-4-methyl- 42 5-phenyl-2-oxazoline).
STATEMENT OF PURPOSE
RS 07868
Add to Idaho Code 37-2711 Schedule 1 of the Uniform Controlled
Substance Act Chapter 27, Title 37, the drug Gamma Hydroxy
Butyrate. This change is being requested because of the increased
abuse of this drug.
FISCAL NOTE
No impact on the General Fund. No cost to the general public or
practitioners. Implementation of legislation will be from the
Board of Pharmacy dedicated funds.
CONTACT: (Lacey Turner)
(332-1160)
STATEMENT OF PURPOSE/ FISCAL NOTE
H 704